| Advanced implantable drug delivery technologies: transforming the clinical landscape of therapeutics for chronic diseases FP Pons-Faudoa, A Ballerini, J Sakamoto, A Grattoni Biomedical microdevices 21, 1-22, 2019 | 155 | 2019 |
| Pharmacokinetics of concomitant cisplatin and paclitaxel administered by hyperthermic intraperitoneal chemotherapy to patients with peritoneal carcinomatosis from epithelial … L Ansaloni, F Coccolini, L Morosi, A Ballerini, M Ceresoli, G Grosso, ... British journal of cancer 112 (2), 306-312, 2015 | 105 | 2015 |
| 3D printed vascularized device for subcutaneous transplantation of human islets M Farina, A Ballerini, DW Fraga, E Nicolov, M Hogan, D Demarchi, ... Biotechnology Journal 12 (9), 1700169, 2017 | 86 | 2017 |
| Transcutaneously refillable nanofluidic implant achieves sustained level of tenofovir diphosphate for HIV pre-exposure prophylaxis CYX Chua, P Jain, A Ballerini, G Bruno, RL Hood, M Gupte, S Gao, ... Journal of controlled release 286, 315-325, 2018 | 77 | 2018 |
| Intratumor heterogeneity and its impact on drug distribution and sensitivity I Fuso Nerini, L Morosi, M Zucchetti, A Ballerini, R Giavazzi, M D'incalci Clinical Pharmacology & Therapeutics 96 (2), 224-238, 2014 | 69 | 2014 |
| Three-dimensional printed polymeric system to encapsulate human mesenchymal stem cells differentiated into islet-like insulin-producing aggregates for diabetes treatment OM Sabek, M Farina, DW Fraga, S Afshar, A Ballerini, CS Filgueira, ... Journal of tissue engineering 7, 2041731416638198, 2016 | 55 | 2016 |
| Nanofluidic drug-eluting seed for sustained intratumoral immunotherapy in triple negative breast cancer CYX Chua, P Jain, A Susnjar, J Rhudy, M Folci, A Ballerini, A Gilbert, ... Journal of controlled release 285, 23-34, 2018 | 52 | 2018 |
| Transcutaneously refillable, 3D-printed biopolymeric encapsulation system for the transplantation of endocrine cells M Farina, CYX Chua, A Ballerini, U Thekkedath, JF Alexander, JR Rhudy, ... Biomaterials 177, 125-138, 2018 | 51 | 2018 |
| Asparagine levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia treated with pegylated-asparaginase in the induction phase of the AIEOP-BFM ALL 2009 … C Rizzari, C Lanvers-Kaminsky, MG Valsecchi, A Ballerini, C Matteo, ... haematologica 104 (9), 1812, 2019 | 36 | 2019 |
| Nanofluidic microsystem for sustained intraocular delivery of therapeutics N Di Trani, P Jain, CYX Chua, JS Ho, G Bruno, A Susnjar, ... Nanomedicine: Nanotechnology, Biology and Medicine 16, 1-9, 2019 | 33 | 2019 |
| Therapeutic Drug Monitoring of Asparaginase Activity—Method Comparison of MAAT and AHA Test Used in the International AIEOP-BFM ALL 2009 Trial C Lanvers-Kaminsky, A Rüffer, G Würthwein, J Gerss, M Zucchetti, ... Therapeutic Drug Monitoring 40 (1), 93-102, 2018 | 21 | 2018 |
| Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia D Caracciolo, C Riillo, A Ballerini, G Gaipa, L Lhermitte, M Rossi, C Botta, ... Journal for immunotherapy of cancer 9 (2), 2021 | 16 | 2021 |
| Counteracting muscle atrophy on Earth and in space via nanofluidics delivery of formoterol A Ballerini, CYX Chua, J Rhudy, A Susnjar, N Di Trani, PR Jain, G Laue, ... Advanced Therapeutics 3 (7), 2000014, 2020 | 12 | 2020 |
| Remote magnetic switch off microgate for nanofluidic drug delivery implants M Farina, A Ballerini, G Torchio, G Rizzo, D Demarchi, U Thekkedath, ... Biomedical microdevices 19, 1-8, 2017 | 11 | 2017 |
| A novel bispecific T-cell engager (CD1a x CD3ε) BTCE is effective against cortical-derived T cell acute lymphoblastic leukemia (T-ALL) cells C Riillo, D Caracciolo, K Grillone, N Polerà, FM Tuccillo, P Bonelli, G Juli, ... Cancers 14 (12), 2886, 2022 | 10 | 2022 |
| Efficacy of sustained delivery of GC-1 from a Nanofluidic system in a spontaneously obese non-human primate: a case study CS Filgueira, G Bruno, ZW Smith, CYX Chua, A Ballerini, M Folci, ... Biomedical Microdevices 20, 1-12, 2018 | 6 | 2018 |
| Pharmacodynamic effects in the cerebrospinal fluid of rats after intravenous administration of different asparaginase formulations A Ballerini, F Moro, IF Nerini, CM Marzo, A Di Clemente, M Ferrari, ... Cancer Chemotherapy and Pharmacology 79, 1267-1271, 2017 | 6 | 2017 |
| Sustained Delivery of Tamoxifen from a Nanofluidic Delivery Platform A Ballerini, C S Filgueira, E Nicolov, P Jain, G Bruno, R L Hood, ... Drug Delivery Letters 6 (2), 127-133, 2016 | 6 | 2016 |
| A pharmacokinetic study of GC-1 delivery using a nanochannel membrane device CS Filgueira, A Ballerini, E Nicolov, CYX Chua, P Jain, ZW Smith, ... Nanomedicine: Nanotechnology, Biology and Medicine 13 (5), 1739-1744, 2017 | 4 | 2017 |
| UMG1/CD3ε‐bispecific T‐cell engager redirects T‐cell cytotoxicity against diffuse large B‐cell lymphoma D Caracciolo, N Polerà, B Belmonte, F Conforti, S Signorelli, A Gulino, ... British Journal of Haematology 204 (2), 555-560, 2024 | 1 | 2024 |
